ArticleCureus2023
Acute Pancreatitis: Clinical Profile of 60 Patients.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Targeting PFKFB3 to restore glucose metabolism in acute pancreatitis via nanovesicle delivery.Molecular medicine (Cambridge, Mass.) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Acute pancreatitis (AP) is a common differential diagnosis of acute pain abdomen and cannot be considered self-limiting as it has serious early and long-term impacts. Depending on severity, AP is divided into mild, moderately severe, and severe AP. Management of AP involves accurate diagnosis, high-quality supportive care, monitoring for early detection and treatment of complications, and prevention of relapse. Aim To assess the etiological risk factors, clinical profile, and complications in patients with AP. Methods The present study was conducted on 60 eligible patients admitted to the Department of Medicine, Government Medical College, and Hospital of Northern India. A diagnosis of AP was established based on the revised Atlanta classification (2012) for the classification of AP, and relevant data were collected and statistically analyzed. Results Most of the AP patients were in the 21-40 year age group. The majority were males (88.3%). Alcohol was the most common etiological factor in 76.7% of patients followed by cholelithiasis in 10% of patients. Pain abdomen was the most common presenting clinical feature occurring in 96.7% of patients and vomiting in 65% of the patients. Acute fluid collection was the most common pancreatic complication occurring in 26.7% of the patients, pancreatic edema was seen in 21.7%, and pancreatic necrosis in 15%. Among extrapancreatic complications, ascites was most commonly seen in 50% of patients followed by pleural effusion in 15%, shock in 15%, multiple organ dysfunction syndrome (MODS) in 15%, and hypocalcemia in 11.7% of patients. Conclusion AP should be one of the differentials for patients presenting with pain abdomen, especially when probable risk factors such as alcohol abuse and cholelithiasis are present. A high index of suspicion to diagnose AP is needed as timely management may prevent systematic complications, thus improving the outcome. Poor prognostic indicators are raised levels of total serum bilirubin, raised serum lipase, reduced serum albumin, and low platelet count among AP patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.